These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6792702)

  • 1. [Bactericidal activity against P. aeruginosa in serum and bronchial secretion in patients under continuous infusion of azlocillin].
    Mombelli G; Coppens L; Thys JP; Klastersky J
    Schweiz Med Wochenschr; 1981 Jan; 111(4):123-5. PubMed ID: 6792702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.
    Bassler M; Depuis W; Utz E; Just HM; Daschner FD
    Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
    Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
    Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of methodology in determining bactericidal and bacteriostatic activities of azlocillin and ticarcillin against Pseudomonas aeruginosa.
    Brumfitt W; Hamilton-Miller JM; Gooding A
    J Med Microbiol; 1984 Feb; 17(1):37-44. PubMed ID: 6420572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.
    White AR; Comber KR; Sutherland R
    Antimicrob Agents Chemother; 1980 Jul; 18(1):182-9. PubMed ID: 6774663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
    Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
    Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
    Zinner SH; Klastersky J; Gaya H; Bernard C; Ryff JC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
    Wang R; Sun XD; Cai QM
    Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis].
    Semykin SIu; Postnikov SS; Polikarpova SV; Dubovik LG; Kolbatova ES
    Antibiot Khimioter; 2005; 50(4):18-22. PubMed ID: 16392335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial effects of the combinations of azlocillin with other antibiotics].
    Courtieu AL; Billaudel S; Reynaud A; Drugeon HB
    Presse Med; 1984 Mar; 13(13):785-7. PubMed ID: 6231595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility and tolerance of beta-lactamase-producing, methicillin-sensitive strains of Staphylococcus aureus towards seven broad-spectrum penicillins.
    Wehrli R; von Graevenitz A; Lüthy R
    Infection; 1983; 11(6):322-5. PubMed ID: 6607889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.